{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T12:32:11Z","timestamp":1771504331690,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4239,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1093\/annonc\/mdn022","type":"journal-article","created":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T01:24:42Z","timestamp":1204075482000},"page":"958-963","source":"Crossref","is-referenced-by-count":179,"title":["Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma"],"prefix":"10.1016","volume":"19","author":[{"given":"S.","family":"Mercadal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Briones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Xicoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Escoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Estany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cam\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Colomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cd.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Guti\u00e9rrez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Montserrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn022_bb0010","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues","first-page":"189","article-title":"Mature T-cell and NK-cell neoplasms","author":"Jaffe","year":"2001"},{"key":"10.1093\/annonc\/mdn022_bb0015","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma","volume":"89","author":"The Non-Hodgkin's Lymphoma Classification Project","year":"1997","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years","volume":"16","author":"Au","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2141.2001.02896.x","article-title":"Anaplastic large cell lymphoma: pathological, molecular and clinical features","volume":"114","author":"Falini","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdn022_bb0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1093\/annonc\/mdn022_bb0035","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B","article-title":"Peripheral T cell lymphoma","volume":"63","author":"Armitage","year":"1989","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn022_bb0040","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1023\/A:1008200307625","article-title":"Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the REAL classification","volume":"8","author":"Ascani","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.","volume":"9","author":"L\u00f3pez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0050","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0060","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/asheducation-2005.1.267","article-title":"Aggressive peripheral T-cell lymphomas (specified and unspecified types)","author":"Savage","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1093\/annonc\/mdn022_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","article-title":"Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Groupe d'Etude des Lymphomes Agressives (GELA)","volume":"1","author":"Coiffier","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0070","first-page":"76","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes Agressives (GELA)","volume":"92","author":"Gisselbrecht","year":"1998","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0075","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/cncr.20531","article-title":"Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T-cell lymphomas unspecified, and 496 diffuse large B-cell lymphomas: experience of the Intergruppo Italiano Linfomi","volume":"101","author":"Morabito","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn022_bb0080","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood-2003-10-3389","article-title":"A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas","volume":"103","author":"Enblad","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0085","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1080\/10428190400028959","article-title":"Effective treatment of a peripheral T-cell lymphoma\/lymphoepitheloid cell variant (Lennert's lymphoma) refractory to chemotherapy with the CD-52 antibody alemtuzumab","volume":"46","author":"Zeitlinger","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdn022_bb0090","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1200\/JCO.2006.07.8972","article-title":"Phase I\/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma","volume":"25","author":"Ansell","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0095","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","article-title":"High-dose chemotherapy and autologous stem cell transplantation in peripheral T cell lymphomas: the GEL\/TAMO experience","volume":"14","author":"Rodriguez","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/10428190310001597955","article-title":"Stem cell transplantation for peripheral T-cell lymphomas","volume":"45","author":"Jantunen","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdn022_bb0105","first-page":"1372","article-title":"High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience","volume":"88","author":"Rodr\u00edguez","year":"2003","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdn022_bb0110","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/annonc\/mdh471","article-title":"All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA)","volume":"15","author":"Mounier","year":"2004","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mdn022_bb0115","first-page":"v56","article-title":"High-dose therapy and autologous stem cell transplant as first line treatment in peripheral T-cell lymphomas","volume":"16","author":"D'Amore","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0120","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","article-title":"Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation","volume":"20","author":"Corradini","year":"2006","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdn022_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.bmt.1705712","article-title":"Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen","volume":"40","author":"Smith","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdn022_bb0130","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1080\/10428190701435275","article-title":"Hematopoietic stem cell transplantation in peripheral T-cell lymphomas","volume":"48","author":"Corradini","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdn022_bb0135","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stages designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1093\/annonc\/mdn022_bb0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdn022_bb0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2307\/2529177","article-title":"Conservatism of the approximation *(O-E)2\/E in the log-rank test for survival data or tumour incidence data","volume":"29","author":"Peto","year":"1973","journal-title":"Biometrics"},{"key":"10.1093\/annonc\/mdn022_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc (B)"},{"key":"10.1093\/annonc\/mdn022_bb0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdn022_bb0165","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":"Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","article-title":"Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL","volume":"103","author":"Tsuchiya","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0175","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1158\/1078-0432.CCR-04-0269","article-title":"Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes","volume":"10","author":"Mart\u00ednez-Delgado","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdn022_bb0180","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdn022_bb0185","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1093\/annonc\/mdn022_bb0190","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","article-title":"Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma","volume":"103","author":"Escalon","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn022_bb0195","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2003-02-0542","article-title":"Intensive conventional (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma","volume":"102","author":"Tilly","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0200","doi-asserted-by":"crossref","first-page":"811a","DOI":"10.1182\/blood.V106.11.811.811","article-title":"International Peripheral T-cell Lymphoma (PTCL) Clinical and Pathology Review Project: poor outcome by prognostic indices and lack of efficacy with anthracyclines","volume":"106","author":"Vose","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn022_bb0205","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","article-title":"Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells","volume":"22","author":"Corradini","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn022_bb0210","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1038\/sj.leu.2404822","article-title":"Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome","volume":"21","author":"Corradini","year":"2007","journal-title":"Leukemia"},{"key":"10.1093\/annonc\/mdn022_bb0215","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419418577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419418577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/5\/958\/402332\/mdn022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T19:43:52Z","timestamp":1738093432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419418577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0923753419418577"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn022","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}